References
- McGovem B, Garan H, Ruskin JN. Precipitation of cardiac arrest by verapamil in patients with Wolff-Parkinson-White syndrome. Ann Intern Med 1986: 104(6): 791–4
- Drury AN, Szent-Gyorgyi A. The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart. J Physiol (Lond) 1929: 68(3): 213–37
- Honey RM, Ritchie WT, Thomson WA. The action of adenosine upon the human heart. Quart J Med 1930: 23(Jul): 485–90
- Belardinelli L, Linden J, Berne RM. The cardiac effects of adenosine. Prog Cardiovasc Dis 1989: 32(1): 73–97
- DiMarco JP, Sellers TD, Berne RM, et al. Adenosine: electrophysiologic effects and therapeutic use for terminating paroxysmal supraventricular tachycardia. Circulation 1983: 68(6): 1254–63
- Caruso AC, Miles WM, Klien LS, et al. Double-blind, placebo-controlled, dose-ranging study of adenosine in patients with supraventricular tachycardia. (Abstr) Circulation 1989: 80(4): 632
- DiMarco JP, Miles W, Akhtar M, et al. Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials. Ann Intern Med 1990: 113(2): 104–10 [erratum, Ann Intern Med 1990 Dec 15]
- Cushley MJ, Tattersfield AE, Holgate ST. Adenosine-induced bronchoconstriction in asthma: antagonism by inhaled theophylline. Am Rev Respir Dis 1984: 129(3): 380–4